TotalMarketCap

Stoke Therapeutics

STOKNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.704 B

$26.06 -5.06%

Close of 6 Nov 2026

As of 6 Nov 2026, Stoke Therapeutics (STOK) has a market capitalization of $1.70B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$184.4M

#2297 by revenue

Earnings

-$6.88M

Loss-making

Shares outstanding

65,406,268

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #100Trevi TherapeuticsTRVI$1.84B
  2. #101Maravai LifesciencesMRVI$1.81B
  3. #102Stoke TherapeuticsSTOK$1.70B
  4. #103Zenas BioPharmaZBIO$1.70B
  5. #104Agios PharmaceuticalsAGIO$1.70B

What if Stoke Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$431,715.10

Per share 16,566× higher

Bitcoin $1.53T

$23,359.35

Per share 896× higher

Apple $5.02T

$76,686.57

Per share 2,943× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Stoke Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.